Immuno-epidemiological model of two-stage epidemic growth by Banerjee, Malay et al.
ar
X
iv
:2
00
3.
14
15
2v
1 
 [q
-b
io.
PE
]  
31
 M
ar 
20
20
Immuno-epidemiological model of
two-stage epidemic growth
Malay Banerjee1, Alexey Tokarev2, Vitaly Volpert3,4,2
1 Department of Mathematics & Statistics, IIT Kanpur, Kanpur - 208016, India
2 Peoples Friendship University of Russia (RUDN University)
6 Miklukho-Maklaya St, Moscow, 117198, Russia
3 Institut Camille Jordan, UMR 5208 CNRS, University Lyon 1, 69622 Villeurbanne, France
4 INRIA Team Dracula, INRIA Lyon La Doua, 69603 Villeurbanne, France
Abstract. Epidemiological data on seasonal influenza show that the growth rate of the
number of infected individuals can increase passing from one exponential growth rate to
another one with a larger exponent. Such behavior is not described by conventional epi-
demiological models. In this work an immuno-epidemiological model is proposed in order
to describe this two-stage growth. It takes into account that the growth in the number of
infected individuals increases the initial viral load and provides a passage from the first stage
of epidemic where only people with weak immune response are infected to the second stage
where people with strong immune response are also infected. This scenario may be viewed
as an increase of the effective number of susceptible increasing the effective growth rate of
infected.
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1 Introduction
On March 22, 2020 according to the official data presented at the Worldometer [17] for
COVID-19, the number of infected individuals exceeded 10 thousand in seven countries.
The respective growth rate of the number of infected is shown in Table 1.
The first column represents the number of days needed to pass from 100 to 1000 infected,
the second column from 1000 to 10000. If the number of days is the same in the two
columns, then the growth is exponential, as it is predicted by conventional epidemiological
models (SIR) for the beginning of epidemic when the number of uninfected (susceptible)
individuals can be considered as approximately constant. In Italy, Iran, and France, the
number of days in the second column is larger than in the first column. In Italy main
restrictions were adopted beyond ten thousand initial infected. In Germany this difference
is small at the moment, so it is early to make conclusions. In USA and Spain the number of
days is the same and the growth rate is slightly larger in Spain.
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100-1000 1000-10000
China - 7
Italy 6 10
USA 8 8
Spain 7 7
Germany 8 9
Iran 5 10
France 7 11
Table 1. Tenfold time of the number of infected individuals in the country where their
total number exceeds 10 thousand on March 22. The first column shows the number of days
required to pass from 100 to 1000 infected, the second column from 1000 to 10 000 infected.
These data should be taken with caution because they can be strongly influenced by the
number of effectuated tests. According to some media reports, there is a shortage of testing
facility and/or shortage of testing kits in many countries, and the accurate number of infected
individuals can be much larger [7].
Dynamics of the number of infected individuals can be influenced by various factors, in
particular, by their spatial distribution and nature of social mixing. Appearance of new
focuses of infection can essentially change the growth curves. For example, at the whole
world level, development of the epidemic in Europe started when it was mostly at decaying
mode in Asia. Instead of the standard growth-decay curves, this leads to growth-decay-
growth curves. Some elements of this more complex dynamics where the number of newly
reported daily cases decreased during several days was also observed in some countries.
If we suppose that the distribution of infected individuals is uniform over space, then the
SIR model predicts the exponential growth at the beginning of epidemic. Some time later,
the growth rate decreases due to the decrease in the number of susceptible individuals, and
the number of infected individuals decays at the end of epidemic. There are recent works
with various modifications of the epidemiological models trying to take into account some
specific features of the coronavirus pandemic [6, 9, 16].
Analysis of the data on seasonal influenza shows that dynamics of epidemic spread can
include the period of accelerated growth (Figure 1). In the beginning of epidemic, the
growth rate is exponential. At the next stage it continues to grow exponentially but with
an increased growth rate. It can be considered as two different exponential functions where
the second one has a larger exponent than the previous one. A possible explanation of this
effect is related to the presence of sub-populations with different response on the infection.
Simplifying the situation, we can consider two sub-populations, one of them with a weak
immune response and another one with a strong immune response. The strength of immune
response is determined by the rate of production of antigen specific immune cells. We will
define it below. At the beginning of epidemic, infection propagates among the first sub-
population. When the epidemic reaches certain level, the second sub-population becomes
also involved increasing the number of susceptible individuals.
Transition between the two stages of epidemic growth can be related to the number of
infected individuals. If it is small enough, then a healthy individual rarely meets infected
individuals, and the initial viral load remain small. People with a strong immune system can
eliminate infection without developing disease symptoms, while people with a weak immune
system can fall sick. At the later stages of epidemic, when the number of infected individuals
is sufficiently large, an uninfected individual can cross several infected individuals during a
2
short period of time. Therefore, the initial viral load becomes larger, and people with a
strong immune response can also become ill.
In order to describe this two stage epidemic growth, we develop in this work an immuno-
epidemiological model combining the individual level and the population level. This model
is generic but it can take into account specific features of a particular infection or the details
of epidemiological situation (like quarantine, social distancing, self-isolation, etc.). In the
next section, we will discuss some epidemiological data on influenza epidemic. Section 3 is
devoted to a model of immune response where we show how people with weak and strong
immune system can react on a given initial viral load. Immuno-epidemiological model is
studied in Section 4.
2 Two stage epidemic
There are large amount of data available for the seasonal influenza epidemic. A typical
graph of the number of cases is shown in Figure 1 (left, blue curve) [5]. Growth rate of the
number of positive cases between weeks 1 and 6 is exponential. The red curve shows the
approximation of the blue curve with the function 20.5 exp(0.2x), where x is the number of
weeks. The same curves are shown in Figure 1 (right) in the logarithmic scale. The red curve
here is a straight line. The weeks 7-10 show different growth rate with some acceleration in
growth. It also corresponds to an exponential growth but with a different exponent. Some
other data are presented in Appendix 1.
Figure 1: Data on seasonal influenza in Europe in 2019-2020 [5]. The left graph shows
the number of influenza-positive specimens from non-sentinel sources (blue line) and its
approximation by an exponential (red line). The right graph shows the same curves in the
logarithmic scale.
Conventional epidemiological models like SIR (Susceptible, Infected, Recovered, see, e.g.,
[11]) and their numerous variants describe the density of infected individuals I by the typical
equation
dI
dt
= λIS − νI, (2.1)
where S and I are the densities of susceptible and infected individuals, and λ is a positive
constant. The first term in the right-hand side of this equation characterizes the appear-
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ance of new infected individuals due to their contact with susceptible. The second term
corresponds to the decrease of I due to the recovery or death of infected individuals.
In the beginning of the infection spreading, the number of infected and recovered indi-
viduals are much less than the number of susceptible, so that we can approximate S by a
constant S ≈ S0. Using this approximation, we obtain a linear differential equation with
constant coefficients. Its solution is given by the function I(t) = I0 exp(αt), where I0 is the
number of infected individuals at the initial moment of time, and α = λS0−ν. If α > 0, then
I(t) exponentially growth. The same condition can be written as R0 > 1, where R0 = λS0/ν
is the basic reproduction number.
Thus, according to equation (2.1), growth of the number of infected individuals is expo-
nential in the beginning of epidemic, and it slows down later when S decreases. Exponential
growth in the beginning corresponds to the data in Figure 1. However, it does not describe
accelerated growth during the second stage of epidemic. A possible explanation of this ac-
celeration is that in the beginning the epidemic, disease spreads mainly among the people
with weak immune response. At the second stage, people with strong immune response be-
come also exposed. In order to investigate this hypothesis, we consider a model of immune
response in the next section.
3 Model of immune response
We consider a qualitative model of immune response suggested in [2]:
dv
dt
= kv(1− v)− σcv, (3.1)
dc
dt
= p(v)c(1− c)− h(v)c, (3.2)
where v and c are the concentrations of viruses and immune cells within the organism. The
first term in the right-hand side of equation (3.1) describes the virus multiplication rate. This
logistic term is proportional to the virus density v and to the normalized density of uninfected
cells (1− v). The second term characterizes virus death due to the immune response. This
term is proportional to the virus density and to the density of immune cells c. The first
term in the right-hand side of equation (3.2) describes multiplication of immune cells and
the second term their mortality. In general, both of them depend on virus concentration.
Clonal expansion of immune cells is stimulated by antigen (virus) if its concentration is not
very large. For large virus concentration, the proliferation rate of immune cells can decrease.
Therefore, the function p(v) is non-negative and increasing with saturation or growing for
small v and decreasing for large v. The death rate of immune cells can also depend on the
concentration of viruses. In this case it is a positive increasing function. It can be also
considered as constant if this effect is negligible.
The nullclines of system (3.1), (3.2) are given by the expressions: v = 0 and c = k(1 −
v)/σ; c = 0 and c = f(v), where f(v) = 1−h(v)/p(v). Figure 2 qualitatively shows possible
phase portraits of this system. There are six stationary points in the left phase portrait
and four in the right one. If there is a small initial virus load v0 and a small number of
c0 for antigen specific immune cells (new infection, no memory cells), then the trajectory
of this system will start from a small vicinity of the unstable stationary point (0, 0) and
move towards one of the other stationary points. Summarizing the behavior of solutions, we
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Figure 2: Two examples of phase portrait of system (3.1), (3.2) depending on the function
f(v) = 1− h(v)/p(v). It can have six (left) or four (right) stationary points. The trajectory
with the initial condition (v0, c0) and sufficiently small viral load v0 can go either to the sta-
tionary point with complete virus elimination (right) or to a weak persistent infection (left).
If the initial viral load is sufficiently large, then the trajectory approaches the stationary
point with large v and small c. It corresponds to a strong chronic infection or to death.
Reprinted from [2].
observe that if the initial viral load v0 is sufficiently small, then the trajectory approaches the
stationary point with complete curing (Figure 2, right) or with a weak persistent infection
(Figure 2, left). If the initial viral load is large enough, then the solution converges to a
stationary point with a large virus concentration and low concentration of immune cells. It
can characterize a strong chronic infection or a lethal outcome. We present some results of
numerical simulations in Appendix 2.
In order to get an explicit solution, we simplify system (3.1), (3.2) with the following
assumptions:
(A1) - functions p(v) and h(v) are constant. This means that the clonal reproduction of
immune cells fully responds to the antigen as soon as there is a small amount of virus in the
organism, and mortality rate of the immune cells does not depend on virus concentration;
(A2) - there is no limitation on the production of viruses and immune cells by available
resources, i.e., the logistic terms in equations (3.1), (3.2) are replaced by the linear terms.
Under these assumptions, instead of system (3.1), (3.2) we consider the following system of
equations:
dv
dt
= kv − σcv, (3.3)
dc
dt
= pc− hc. (3.4)
We find from equation (3.4), c = c0e
µt, where c0 is the number of antigen specific immune
cells initially, and µ = p−h. Assuming that µ > 0, we obtain exponential growth of immune
cells. Substituting the solution for c into equation (3.3), we find the solution for v as
v(t) = v0e
kt−
c0σ
µ
(eµt−1) ,
where v0 is the initial viral load. The derivative of this function
v′(t) = v0
(
k − c0σe
µt
)
ekt−
c0σ
µ
(eµt−1)
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is positive at t = 0 since the initial number c0 of antigen specific cells is very small. Therefore,
v(t) grows at the beginning of infection development. This derivative equals 0 at time
t∗ =
1
µ
ln
(
k
c0σ
)
when the maximal virus concentration is reached. After that, it decreases
and converges to 0. The maximal virus concentration is as follows:
v∗ = v0e
(w lnw−w+1)/s ,
where w = k/(c0σ), s = (p− h)/(c0σ). Parameter w corresponds to the dimensionless virus
multiplication rate. It characterizes the virulence of infection. Parameter s characterizes the
strength of the immune response.
The maximal level of viral concentration is determined by the initial viral load v0, the
virulence of infection w, and the strength of immune response s. For a given virulence
of infection w > 1, the maximal viral load increases with for larger initial viral loads and
decreases for stronger immune response. If we setW = w lnw−w+1, then v∗ = v0 exp(W/s).
Suppose that there are two levels of immune response s1 and s2, with s1 < s2. The first
one corresponds to weak immune response and s2 to strong immune response. For a given
initial viral load v0, the corresponding maximal virus concentrations are v
∗
1 and v
∗
2, where
v∗1 > v
∗
2 . Disease development depends on virus concentration in a threshold way. If its level
exceeds some critical value, which is determined by a proportion of infected tissue, then
disease symptoms are developed, and the person is considered as infected and fall sick. If
this critical level of virus concentration vc is such that v
∗
1 > vc > v
∗
2, then people with weak
immune response become ill while people with strong immune response remain healthy. The
same property is preserved in the full model, where s1 < s2 leads to v
∗
1 > v
∗
2 for the same v0
(see Appendix 2).
However, if the initial virus load increases with the progression of epidemic, then v∗2 also
increases and it can overpass the critical level. We consider this question in the next section.
4 Immuno-epidemiological model
We can now bring together the epidemiological model and the immune response model
making a link between the number of infected individuals I, the initial viral load v0, and
the number of susceptible individuals S. We suppose that the v0 = v0(I) and S ≈ S(v0) =
S(v0(I)). Hence, the number of susceptible becomes a function of the number of infected.
SIR model. Under the assumption that the number of susceptible individuals depends on
the number of infected through the initial viral load, we obtain a closed equation for the
number of infected:
dI
dt
= λIS(v0(I))− νI. (4.1)
As before, let us assume that the total population consists of two sub-populations, one of
them with weak immune response and another one with strong immune response. If the
initial viral load v0 is less than some critical value vˆ0, then the maximal viral concentration
in the case of strong immune response remains less than the critical level vc which determines
the appearance of the disease. This critical viral level can be determined from the equality
vc = vˆ0 exp(W/s2). Hence
S(v0) =
{
S1, v0 < vˆ0
S2, v0 ≥ vˆ0
,
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where S1 corresponds to the sub-population with weak immune response and S2 to the total
population. Under this assumption, the explicit dependence v0(I) is not needed. We suppose
that the viral load is an increasing function such that v0(I) < vˆ0 for I < Ic, and v0(I) ≥ vˆ0
for I ≥ Ic. Then instead of equation (4.1) we can write:
dI
dt
= λIS1 − νI , I < Ic ;
dI
dt
= λIS2 − νI , I ≥ Ic . (4.2)
We can now find the solution:
I(t) = I0e
α1t , 0 < t < tc =
1
α1
ln
(
Ic
I0
)
, I(t) = Ice
α2(t−tc) , tc < t .
Here α1 = λS1 − ν, α2 = λS2 − ν. Hence, the number of infected individuals grows with
exponent α1 till some critical time tc, and with a larger exponent α2 for t > tc.
Quarantine model. Another epidemiological model was introduced in [16], in order to
take into account removal of infected individuals to quarantine when the incubation period
is finished and they manifest disease symptoms:
dI
dt
= λI(t)S(t)− λI(t− τ)S(t− τ). (4.3)
Here I(t) is the density of latently infected individuals (during the incubation period), τ is
the length of the incubation period. In this case we have three time intervals: 0 < t < tc
where tc is such that I(tc) = Ic; tc < t < tc + τ , and t > tc + τ . We assume S(t) = S1,
S(t− τ) = S1 for 0 < t < tc, and the solution of equation (4.3) is as follows:
I(t) = I0e
µ1t , 0 < t < tc,
where I0 is the initial number of latently infected individuals, and µ1 satisfies the equation
µ1 = kS1(1− e
−µ1τ ). This equation has a positive solution if the basic reproduction number
R1 = λS1τ is greater than 1. Let us recall that R1 characterizes the number of newly
infected individuals during the incubation period. The value tc can be found from the
equality I(tc) = Ic, tc =
1
µ1
ln
(
Ic
I0
)
.
During the second time interval tc < t < tc + τ , we have S(t) = S2 and S(t − τ) = S1.
The solution of equation (4.3) writes:
I(t) = Ice
µ2(t−tc) , tc < t < tc + τ,
where µ2 satisfies the equality µ2 = λS2(1 − θe
−µ2τ ), θ = S1/S2. Since θ < 1, this equation
has a positive solution and hence µ2 > 0.
If t > tc + τ , then S(t) = S2, S(t− τ) = S2,
I(t) = I1e
µ3(t−tc−τ) , t > tc + τ,
where I1 = Ice
µ2τ , and µ3 satisfies the equation µ3 = kS2(1 − e
−µ3τ ). This equation has a
positive solution if the basic reproduction number R2 = λS2τ is larger than 1.
Let us note that µ1 < µ3 < µ2. Therefore, the final growth rate is larger than the initial
one but less than the intermediate.
7
5 Discussion
Numerous data on seasonal influenza epidemic shows that growth of the number of infected
individuals can occur in two stages. Both of them are characterized by an exponential
growth rate but the second exponent is larger than the first one. Growth accelerates when
the number of infected reaches certain threshold. It should be noted that usually several virus
strains are observed during influenza epidemic. All of them show similar growth pattern.
Such dynamics can not be captured by conventional epidemiological models like SIR
(susceptible-infected-recovered). These models predict exponential growth at the beginning
of epidemic when the number of susceptible S can be considered as approximately constant
or too large compared to initial number of infected. During the disease progression, S
decreases, as a consequence the growth rate of disease progression also decreases. The
number of infected passes through a maximum and then decays to 0.
The goal of this work is to develop a minimal mathematical model which can describe
accelerated growth of disease spread. Our main hypothesis is that this acceleration can
occur if we take into account the presence of different sub-populations, namely, with weak
and strong immune response. In the beginning of epidemic, only (or mainly) people with
weak immune response are concerned while at the second stage people with strong immune
response also become susceptible. This transition takes place when the number of infected
individuals becomes significantly large, and an uninfected individual has enhanced probabil-
ity of interactions with infected individuals. This increases the viral load received during a
short period of time and leads to the disease propagation in the sub-population with strong
immune response.
In order to analyze how the initial viral load influences the disease initiation and progres-
sion, we consider an immuno-epidemiological model describing the concentration of viruses
and immune cells in the organism. The strength of immune response in the model is deter-
mined by the rate of multiplication of immune cells. We show that for the same initial viral
load, an individual with a weak immune system falls ill while an individual with a strong im-
mune system does not develop disease symptoms. However, if the initial viral load increases,
then the individuals with strong immune response also start developing the disease.
The combination of immunological and epidemiological models allows the description of
the interplay between the population level and individual level [3, 4, 10, 14, 15]. We use here
this approach to study a possible acceleration of epidemic growth rate.
We describe a generic situation applicable to different types of epidemics. During the
influenza epidemic, the critical level of incidences when the growth accelerates is from 50 to
150 per week over 100 000 of the population (Figures 1, 3, 4). Taking into account that the
disease duration is about one week, then we get an estimate of the number of simultaneously
infected individuals. The situation is different for the coronavirus infection because the dis-
ease duration is longer (about 4 weeks) and because the patients with manifested symptoms
are put in quarantine. Therefore, we need to take into account here only the latently infected
individuals during the incubation period. For a country with the total population 10 million
and duration of the incubation period is one week, the critical level of epidemic is about 1400
new daily cases. This estimate does not take into account the restrictions on the population
movement (it does not affect the influenza epidemic).
The immuno-epidemiological model developed in this work is not pathogen specific. We
suppose that it can be also applied to coronavirus infection since the strength of adaptive
immune response plays important role in the disease progression [8]. It should be noted that
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in some cases excessive immune response can damage lung tissue and provoke important
clinical consequences.
Limitations of the model. The main hypothesis of this work is that epidemic progression
begins with a sub-population characterized by weak immune response and, at a later stage,
it continues in the whole population. Though this assumption seems plausible, we do not
have direct confirmation that this heterogeneity of the population plays a significant role
during epidemic spread.
A particular choice of the epidemiological model is not essential here since all of them give
exponential growth for the number of infected individuals. The exponential growth rate is
proportional to the density of susceptible individuals. Once we suppose that effective density
of susceptible can increase during epidemic because different sub-populations are involved
one after another, we can obtain the increase of the growth rate.
The immunological model used in this study is very simplified. It does not take into
account for the involvement of many different cell types, intracellular regulation, time delay
in virus production and clonal expansion of immune cells, and some other relevant aspects.
However, it captures the main features of the interaction of viral infection with the immune
response. Its simplicity allows to couple it with the epidemiological model.
Let us note that system (3.1), (3.2) can also be explicitly solved if the functions p(v) and
h(v) are linear (and the second assumption is satisfied).
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6 Appendix 1. Influenza epidemic data
We present here some typical data on influenza epidemic (Figures 3, 4). The two stage
growth can be observed.
7 Appendix 2. Solution of the immunological system
We present here some results of numerical simulations of system (3.1), (3.2) with the func-
tions p(v) = (p0 + p1v)e
−p3v, h(v) = h1v, where p0 = 0.2, p1 = 5 (Figure 5) and p1 = 10
(Figure 6), p3 = 4, h1 = 0.2. Other two parameter values are k = 1 and σ = 1.
The strength of immune response is characterized by the parameter p1 which determines
the rate of clonal expansion of immune cells in response to the antigen. A lesser value of p1
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Figure 3: Data on seasonal influenza in UK [12]. The left graph shows the number of
influenza-positive specimens from non-sentinel sources (blue line) and its approximation by
an exponential (red line). The right graph shows the same curves in the logarithmic scale.
Figure 4: Data on seasonal influenza in Belgium [13]. The left graph shows the number of
influenza-positive specimens from non-sentinel sources (blue line) and its approximation by
an exponential (red line). The right graph shows the same curves in the logarithmic scale.
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Figure 5: Trajectories on the phase plane of system (3.1), (3.2) in the case of weak immune
response (left) and two sample plots for the growth of v(t) with time (right).
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Figure 6: Trajectories on the phase plane of system (3.1), (3.2) in the case of strong immune
response (left) and two sample plots for the growth of v(t) with time (right).
corresponds to weaker immune response (Figure 5), a larger value of p1 to stronger immune
response (Figure 6).
There are 7 trajectories in each figure starting from the same (pairwise) initial condition
for some small values v = v0 (initial viral load) and c = c0 (initial concentration of antigen
specific cells). If the initial viral load is sufficiently small, then in both cases the trajectories
converge to the virus-free stationary point corresponding to the curing. However, in the
case of strong immune response the maximal and the total virus concentrations are less.
Therefore, strong immune response can prevent the development of the disease while weak
immune response may not be sufficient for this. If the initial viral load is sufficiently large,
then weak immune response can lead to a chronic infection or to death while strong immune
response leads to virus eradication.
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